Growth Metrics

Idexx Laboratories (IDXX) Total Non-Current Liabilities (2016 - 2025)

Idexx Laboratories has reported Total Non-Current Liabilities over the past 17 years, most recently at $596.6 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $596.6 million for Q4 2025, down 5.34% from a year ago — trailing twelve months through Dec 2025 was $596.6 million (down 5.34% YoY), and the annual figure for FY2025 was $596.6 million, down 5.34%.
  • Total Non-Current Liabilities for Q4 2025 was $596.6 million at Idexx Laboratories, up from $573.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for IDXX hit a ceiling of $1.0 billion in Q2 2021 and a floor of $573.7 million in Q3 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $860.4 million (2023), compared with a mean of $831.1 million.
  • Biggest five-year swings in Total Non-Current Liabilities: increased 7.65% in 2021 and later fell 23.95% in 2025.
  • Idexx Laboratories' Total Non-Current Liabilities stood at $983.6 million in 2021, then decreased by 8.28% to $902.2 million in 2022, then decreased by 8.69% to $823.8 million in 2023, then decreased by 23.5% to $630.2 million in 2024, then dropped by 5.34% to $596.6 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $596.6 million (Q4 2025), $573.7 million (Q3 2025), and $648.1 million (Q2 2025) per Business Quant data.